Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2010 / Cilt: 44 - Sayı: 1

Diltiazem over dose: Case report

Diltiazem intoksikasyonu: Bir olgu sunumu

Pages
41–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because of sustained retain and long half life, the toxication which is due to high dose usage is more fatal than other cardiovascular druge. ‹n this study, it is aimed to check out the clinical signs, symptoms and their solutions which can be encountered in toxication of diltiazem which is one of the calcium channel blockers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Calcium channel blockers are commonly used in the treatment of hypertension, angina pectoris, coronary arter spasm and supraventriculer arrhythmia.
📊
Key Findings & Data:Calcium channel blockers are commonly used in the treatment of hypertension, angina pectoris, coronary arter spasm and supraventriculer arrhythmia.
💡
Conclusion & Impact:Because of sustained retain and long half life, the toxication which is due to high dose usage is more fatal than other cardiovascular druge. ‹n this study, it is aimed to check out the clinical signs, symptoms and their solutions which can be encountered in toxication of diltiazem which is one of the calcium channel blockers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Calcium channel blockers are commonly used in the treatment of hypertension, angina pectoris, coronary arter spasm and supraventriculer arrhythmia. Because of sustained retain and long half life, the toxication which is due to high dose usage is more fatal than other cardiovascular druge. ‹n this study, it is aimed to check out the clinical signs, symptoms and their solutions which can be encountered in toxication of diltiazem which is one of the calcium channel blockers.

Özet

Kalsiyum kanal blokerleri hipertansiyon, anjina pektoris, koroner arter spazmı ve supraventriküler aritmilerin tedavisi için sıkça kullanılırlar. Yavaş salınımlı ve uzun yarılanma ömürleri nedeniyle, yüksek dozlarda kullanımına bağlı oluşan toksikasyonları diğer kardiyovasküler ilaçlardan daha ölümcüldür. Bu olgu sunumunda kalsiyum kanal blokerlerinden biri olan diltiazem intoksikasyonunda karşılaşılabilecek klinik bulgu, belirti ve çözümlerin gözden geçirilmesi amaçlanmıştır.

🔖

Cite This Article

TÜRK, H. Ş., TOTOZ, T., ÇINAR, S., İDİ, İ., OBA, S. (2010). Diltiazem over dose: Case report. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 44 - Sayı: 1, 41–44. https://ajindex.com/articles/363856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Watson, W.A.; Litovitz, T.L.; Rodgers, G.C. Jr.; Klein-Schwartz, W.; Youniss, J.; Rose, S.R.; 922 Borys, D.; May, ME. 2002 Annual Report of the American Association of Poison Control 923 Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 2003, 21 (5):353-421
  2. Salhanick SDS, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26: 65-79
  3. Kenny J. Calcium channel blocking agents and the heart. BMJ 1985;291: 1150-52
  4. Newton CR, Delgado JH, Gomez HF. Calcium and beta receptor antagonist overdose: a review and update of pharmacological principles and management. Semin Respir Crit Care Med 2002; 23: 19-25
  5. Hyperinsulinaemia euglycaemia therapy in the management of overdose of calcium channel blockers. Crit Care 2006; 10: 212.